Abstract
A 52 year-old Australian male of Italian descent began experiencing blisters and erosions on his trunk, face, scalp and mouth in November 2002. Skin biopsy revealed an intraepidermal suprabasal split, and on direct immunofluorescence, IgG and C3 were positive intercellularly in the epidermis. He was admitted to hospital and commenced on 25 mg prednisolone. He discharged himself against medical advice and re-presented at our centre 4 months later in pain with widespread erosions and crusting on his face, scalp, chest, back and mouth, along with hypertension with a blood pressure of 148/118 (Fig. 4.1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gupta V, Kelbel T, Nguyen D, Melonakos K, Murrell D, Xie Y, et al. A globally available internet-based patient survey of pemphigus vulgaris: epidemiology and disease characteristics. Dermatol Clin. 2011;29(3):393–404.
Venugopal S, Murrell D. Diagnosis and clinical features of pemphigus vulgaris. Dermatol Clin. 2011;29(3):373–80.
Amagai M, Koch P, Nishikawa T, Stanley J. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol. 1996;106(2):351–5.
Ding X, Diaz L, Fairley J, Giudice G, Liu Z. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol. 1999;112(5):739–43.
Chernyavsky A, Arrendondo J, Kitajima Y, Sato-Nagai M, Grando S. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem. 2007;282(18):13804–12.
Grando S. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity. 2011;45(1):7–35.
Harman K, Albert S, Black M. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2003;149(5):926–37.
Enk A, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol. 1999;135(1):54–6.
Mimouni D, Anhalt G, Cummins D, Kouba D, Thorne J, Nousari C. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol. 2003;139(6):739–42.
Daniel B, Murrell D, Joly P. Rituximab and its use in autoimmune bullous disorders. Dermatol Clin. 2011;29(4):571–5.
Chams-Davatchi C, Esmaili N, Daneshpazhooh M, Valikhani M, Balighi K, Hallaji Z, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57(4):622–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Maher, N.G., Murrell, D.F. (2015). A 52-Year-Old Italian Male with Widespread Blistering and Erosions Refractory to Regular Dose Prednisone. In: Murrell, D. (eds) Clinical Cases in Autoimmune Blistering Diseases. Clinical Cases in Dermatology, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-319-10148-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-10148-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10147-7
Online ISBN: 978-3-319-10148-4
eBook Packages: MedicineMedicine (R0)